Medtech company HighLife picks up Series B funding

Paris-based HighLife SAS, a medtech company, has raised 32 million euros in Series B funding. U.S. Venture Partners and Andera Partners led the round.

Source: Press Release

PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising news, people moves, regulatory updates and much more every Thursday. Subscribe now! It’s FREE.

Find new deal opportunities, super-charge your fundraising efforts and track top managers with VCJ. Get your FREE trial! Or subscribe now!